Next Article in Journal
Treatment in AL Amyloidosis: Moving towards Individualized and Clone-Directed Therapy
Next Article in Special Issue
Will Mass Spectrometry Replace Current Techniques for Both Routine Monitoring and MRD Detection in Multiple Myeloma?
Previous Article in Journal
Barriers and Facilitators of Use of Hydroxyurea among Children with Sickle Cell Disease: Experiences of Stakeholders in Tanzania
Previous Article in Special Issue
Diffusion-Weighted MRI—The Way Forward for MRI in Myeloma?
 
 
Review

Article Versions Notes

Hemato 2021, 2(4), 727-738; https://doi.org/10.3390/hemato2040049
Action Date Notes Link
article xml file uploaded 2 December 2021 09:57 CET Original file -
article xml uploaded. 2 December 2021 09:57 CET Update -
article pdf uploaded. 2 December 2021 09:57 CET Version of Record -
article xml file uploaded 2 December 2021 09:57 CET Update -
article xml uploaded. 2 December 2021 09:57 CET Update https://www.mdpi.com/2673-6357/2/4/49/xml
article pdf uploaded. 2 December 2021 09:57 CET Updated version of record https://www.mdpi.com/2673-6357/2/4/49/pdf
article html file updated 2 December 2021 10:00 CET Original file -
article html file updated 2 December 2021 10:10 CET Update -
article html file updated 2 December 2021 10:18 CET Update -
article html file updated 30 July 2022 20:05 CEST Update https://www.mdpi.com/2673-6357/2/4/49/html
Back to TopTop